Identity on this record
Composition: BPC-157 5 mg + TB-500 5 mg.
CAS number: Not applicable — composite material.
Appearance: White to off-white lyophilised blend.
Catalog strength: 10 mg total fill.
Those identifiers describe Wolverine as a substance. They do not describe a particular vial. The vial is identified by the name, the nominal fill, and the lot number on its label, checked against the published certificate.
What the catalogue actually sells
Wolverine 10mg is the 10 mg blend lyophilized unit, listed at AED 449 before VAT. The product record stores that sealed unit at 2–8 °C · protect from light.
Prices are merchandise prices in AED, exclusive of VAT. VAT is added at checkout. A price on this summary is the figure on the product record for Wolverine, not a delivered-cost quote.
Lots and certificates
Lot 238923 for Wolverine 10mg is a Janoshik Analytical report. The published record states Content reported. Figures printed on the report: BPC-157 5.65 mg; TB-500 (TB4) 5.61 mg. Method line on that report: BPC-157/TB-500 blend analysis. The laboratory file is linked from the certificate page. Open Wolverine 10mg certificate or match lot 238923 in batch verification. That report qualifies this lot only.
Lot VL-WOLV-20260801 is the catalogue certificate for Wolverine 10mg. Read it on Wolverine 10mg certificate and match the vial in batch verification. A certificate for a different strength, or for a blend that merely contains the same name, does not release this unit.
Wolverine has both a laboratory report and catalogue certificates. Janoshik Analytical lot 238923 is the third-party file. The other lot numbers are catalogue certificates for their own fills. Match the printed lot. Do not treat one purity line as the result for every vial.
How the compound record describes the literature
BPC-157 and TB-500 appear separately in preclinical repair-model literature. Blend presentations consolidate procurement but require component-aware COA review.
Topics named on the Wolverine record, as literature context rather than as outcomes VaultLabs claims: Dual-component repair-pathway documentation; Blend vs single-SKU analytical comparisons; Component identity and ratio verification.
That is context for identifying Wolverine. It is not a claim that a vial produces a result in a person, an animal, or a study VaultLabs has not published. VaultLabs does not provide dosage, administration, study-design, or medical guidance.
Points the monograph already states
Points already written on the Wolverine monograph, so a reader can check them against that page:
Two named components: BPC-157 5 mg and TB-500 5 mg in a 10 mg total fill.
No single CAS registry number — blends are not single substances.
Distinct from BPC-157 10mg (single sequence) and from KLOW (four-component blend).
BPC-157 and TB-500 each have separate literature; combining them does not create new clinical evidence.
Not for human or veterinary use.
Dispatch and the research-use boundary
VaultLabs dispatches Wolverine from Dubai. Orders leave fulfillment within 24 hours, 7 days a week. Standard delivery is AED 35 to every emirate, and delivery is free when the post-discount merchandise subtotal is AED 500 or more. Checkout shows the fee for the address entered. All VaultLabs products are supplied strictly for laboratory and research use only. They are not intended for human consumption, medical use, personal use, or diagnostic use. VaultLabs does not provide dosage, administration, study-design, or medical guidance.
The full narrative record is the Wolverine compound monograph. Handling of the sealed unit is the Wolverine storage guide. Questions are collected on the Wolverine FAQ. How it differs from neighbouring records is the Wolverine comparison.